Sleep Apnea in Elderly

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age60-89
SponsorVA Office of Research and Development

About this trial

Sleep-disordered breathing (SDB or sleep apnea) is very common among elderly Veterans and leads to increased morbidity and mortality in this population. The proposal aims to identity whether oxygen, finasteride and acetazolamide can be effective in reducing unstable breathing and eliminating sleep apnea in the elderly via different mechanisms. This proposal will enhance the investigators' understanding of the pathways that contribute to the development of sleep apnea in the elderly. The investigators expect that the results obtained from this study will positively impact the health of Veterans by identifying new treatment modalities for sleep apnea. A cumulative effect of the investigators' research will fulfill the long-term goal of improving the quality of life of elderly Veterans suffering from sleep apnea and its potential life-threatening complications.

Eligibility criteria

Qualifiers

Adults who are 60 years old and older, with mild to moderate sleep apnea with AHI >/=5 to 20/hr with central, obstructive, mixed apneas and hypopneas.

For the finasteride protocol elderly men with above criteria will be enrolled.

Disqualifiers

Patients with severe sleep apnea (AHI>20/hr)

Patients with history of prostate cancer

Males with hypogonadism

History of cardiac disease, including myocardial infarction

Trial design

Treatments tested in this trial

  • Hyperoxia/oxygen
  • Acetazolamide
  • Finasteride

Treatment groups

100 Participants
are divided into 3 treatment groups